Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alan K. Matsumoto
Observed names:
A K Matsumoto,
Alan K Matsumoto,
Alan Matsumoto
Institution:
Arthritis and Rheumatism Associates
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Johns Hopkins University,
George Washington University,
Johns Hopkins Medicine,
Arthritis and Rheumatism Associates,
Johns Hopkins Hospital
show all 6
OpenAlex ID:
A5109808317
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study
2017
·
Stanley Cohen
, Mark C Genovese
, et al.
·
Annals of the Rheumatic Diseases
·
199
PDF
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
2002
·
Alan K Matsumoto
, Agustin Melian
, et al.
·
PubMed
·
146
Spirituality, well‐being, and quality of life in people with rheumatoid arthritis
2003
·
Susan J. Bartlett
, Ralph Piedmont
, et al.
·
Arthritis Care & Research
·
142
Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial
2005
·
Alan K. Matsumoto
, Najib Babul
, et al.
·
Pain Medicine
·
118
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six‐month, double‐blind, randomized, dose‐ranging study
2002
·
Daniel E. Furst
, Kenneth Saag
, et al.
·
Arthritis & Rheumatism
·
110
T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V3, V14, and V17 Peptides
1998
·
Larry W. Moreland
, Elizabeth E. Morgan
, et al.
·
Arthritis & Rheumatism
·
76
A Randomized, Double‐Blind , Sham‐Controlled , Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
2023
·
Matthew C. Baker
, Sarah Kavanagh
, et al.
·
Arthritis & Rheumatology
·
52
Resolution of gouty tophi after twelve weeks of pegloticase treatment
2008
·
Herbert S. B. Baraf
, Alan K. Matsumoto
, et al.
·
Arthritis & Rheumatism
·
46
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
2019
·
Stanley Cohen
, Jose L. Pablos
, et al.
·
Arthritis Research & Therapy
·
39
PDF
Pain management in osteoarthritis: A focus on onset of efficacy—a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials
2004
·
Wendy P. Battisti
, Nathaniel P. Katz
, et al.
·
Journal of Pain
·
37
Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial
2004
·
Alan J. Kivitz
, Maria W. Greenwald
, et al.
·
Journal of the American Geriatrics Society
·
35
Three cases of osteonecrosis of the lunate bone of the wrist in scleroderma.
1999
·
A K Matsumoto
, R Moore
, et al.
·
PubMed
·
28
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3
2021
·
Daniel Aletaha
, René Westhovens
, et al.
·
RMD Open
·
20
PDF
Oral extended-release oxymorphone: a new choice for chronic pain relief
2007
·
Alan K Matsumoto
·
Expert Opinion on Pharmacotherapy
·
19
Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial
2007
·
Alan Matsumoto
, Agustin Melian
, et al.
·
Current Medical Research and Opinion
·
13
Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial
2025
·
Michael M. Ward
, Arthur Weinstein
, et al.
·
Seminars in Arthritis and Rheumatism
·
4
PDF
Pegloticase: a new biologic for treating advanced gout
2012
·
Herbert SB Baraf
, Alan K Matsumoto
·
International Journal of Clinical Rheumatology
·
2
Patient-Reported Outcomes Following Discontinuation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Remission/Low Disease Activity: A Randomized Placebo-Controlled Trial
2026
·
Michael M. Ward
, Arthur Weinstein
, et al.
·
The Journal of Rheumatology
PDF
Anti-Tumor Necrosis Factor Agents
2003
·
Alan K. Matsumoto
, Joan M. Bathon
·
Humana Press eBooks
Anti-Tumor Necrosis Factor Agents
2002
·
Alan K. Matsumoto
, Joan M. Bathon
·
Humana Press eBooks
Show more works
View as search
Works count:
20
Citation count:
1,086
H-index:
14
I10-index:
15
Year
Topic
Type